{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:03:02Z","timestamp":1788238982709,"version":"build-2803163510"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772079"],"award-info":[{"award-number":["81772079"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"\n Background<\/jats:title>\n Keloid disease is hard to fully eradicate. Recurrence and other unsatisfactory results were found in many patients. No current therapeutic modality has been determined to be most effective for treating keloid scars. Intralesional corticosteroid injections is most commonly recommended for primary management of small and young keloids as well as hypertrophic scars. However, it\u2019s difficult for patients to adhere to long-term triamcinolone acetonide injection therapy because of the pain, inconvenience or complications including hormonal imbalance or irregular menstruation.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n We aimed to determine whether and how Strontium-90 brachytherapy as an adjuvant radiation could affect keloid recurrence after intralesional triamcinolone and 5-fluorouracil injections.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We included keloid patients from March 2019 to September 2019 and randomly allocated them to two groups after 3 intralesional triamcinolone and 5-fluorouracil injections at 3 weeks interval. The experimental group received Strontium-90 brachytherapy at a total dose of 15-20Gy, while the control group didn\u2019t receive any adjuvant treatment. We performed both Vancouver Scar Scale scoring and Color Doppler ultrasound examination to monitor and evaluate lesions regularly. A one-year follow-up was completed for each patient.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n 31 patients who had 42 keloids in total were recruited. We found intralesional triamcinolone and 5-fluorouracil injections could effectively reduce the thickness and modify the hardness of small and young keloids. Strontium-90 brachytherapy reduced the one-year recurrence rate from 85.7 percent to 44.4 percent after 3 intralesional triamcinolone and 5-fluorouracil injections. The lesions\u2019 thickness or elasticity was not affected by Strontium-90 brachytherapy.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Strontium-90 brachytherapy as an adjuvant radiation could effectively reduce small sized keloids recurrence after intralesional triamcinolone and 5-fluorouracil injections. It worked by enhancing the lesions\u2019 stability post-injection.<\/jats:p>\n <\/jats:sec>\n \n Trial registration<\/jats:title>\n \n The clinical trial registration number:\n ChiCTR2000030141<\/jats:ext-link>\n .\n <\/jats:p>\n \n Name of trial registry: Chinese Clinical Trial Registry (\n http:\/\/www.chictr.org.cn\/<\/jats:ext-link>\n )\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pone.0248799","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T13:51:20Z","timestamp":1616507480000},"page":"e0248799","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Strontium-90 brachytherapy following intralesional triamcinolone and 5-fluorouracil injections for keloid treatment: A randomized controlled trial"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6454-9129","authenticated-orcid":true,"given":"Ke","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4574-7880","authenticated-orcid":true,"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,3,23]]},"reference":[{"key":"pone.0248799.ref001","first-page":"33","article-title":"Keloids: A review of etiology, prevention, and treatment","volume":"13","author":"U Betarbet","journal-title":"J Clin Aesthet Dermatol"},{"key":"pone.0248799.ref002","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jpra.2019.09.004","article-title":"Keloid pathophysiology: fibroblast or inflammatory disorders?: Pathophysiology of Keloids.","volume":"22","author":"FW Nangole","year":"2019","journal-title":"JPRAS Open"},{"key":"pone.0248799.ref003","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1524-4725.2008.34406.x","article-title":"Hypertrophic scars and keloids\u2014A review of their pathophysiology, risk factors, and therapeutic management","volume":"35","author":"D Wolfram","year":"2009","journal-title":"Dermatologic Surg"},{"key":"pone.0248799.ref004","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2147\/CCID.S35252","article-title":"Management of keloids and hypertrophic scars: current and emerging options","volume":"6","author":"GG Gauglitz","year":"2013","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"pone.0248799.ref005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2119\/molmed.2009.00153","article-title":"Hypertrophic scarring and keloids: Pathomechanisms and current and emerging treatment strategies","volume":"17","author":"GG Gauglitz","year":"2011","journal-title":"Mol Med"},{"key":"pone.0248799.ref006","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/0378-6323.74968","article-title":"Standard guidelines of care: Keloids and hypertrophic scars","volume":"77","author":"S Gupta","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"pone.0248799.ref007","doi-asserted-by":"crossref","first-page":"620","DOI":"10.5999\/aps.2014.41.6.620","article-title":"Recent developments in the use of intralesional injections keloid treatment","volume":"41","author":"AT Perdanasari","year":"2014","journal-title":"Arch Plast Surg"},{"key":"pone.0248799.ref008","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2147\/CCID.S133672","article-title":"Triamcinolone acetonide intralesional injection for the treatment of keloid scars: Patient selection and perspectives","volume":"11","author":"MM Coppola","year":"2018","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"pone.0248799.ref009","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/00006534-200208000-00031","article-title":"International clinical recommendations on scar management","volume":"110","author":"TA Mustoe","year":"2002","journal-title":"Plast Reconstr Surg"},{"key":"pone.0248799.ref010","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1308\/rcsann.2017.0156","article-title":"Intralesional excision with topical intralesional cryotherapy improves the treatment of keloid scarring in a paediatric patient.","volume":"99","author":"D Reissis","year":"2017","journal-title":"Ann R Coll Surg Engl"},{"key":"pone.0248799.ref011","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s13555-016-0118-5","article-title":"5-Fluorouracil in the Treatment of Keloids and Hypertrophic Scars: A Comprehensive Review of the Literature","volume":"6","author":"VV Shah","year":"2016","journal-title":"Dermatol Ther (Heidelb)."},{"key":"pone.0248799.ref012","first-page":"27","article-title":"Chinese consensus panel on the prevention and treatment of scars. Chinese expert consensus on clinical prevention and treatment of scar","volume":"6","author":"K Lv","year":"2018","journal-title":"Burn trauma"},{"key":"pone.0248799.ref013","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/02844310500430003","article-title":"Long-term outcome of intralesional injection of triamcinolone acetonide for the treatment of keloid scars in Asian patients","volume":"40","author":"G Muneuchi","year":"2006","journal-title":"Scand J Plast Reconstr Surg hand Surg"},{"key":"pone.0248799.ref014","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.burns.2018.08.011","article-title":"Comparison of efficacy and safety of intralesional triamcinolone and combination of triamcinolone with 5-fluorouracil in the treatment of keloids and hypertrophic scars: Randomised control trial","volume":"45","author":"FA Khalid","year":"2019","journal-title":"Burns"},{"key":"pone.0248799.ref015","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/iwj.12629","article-title":"Efficacy and safety of triamcinolone acetonide alone and in combination with 5-fluorouracil for treating hypertrophic scars and keloids: a systematic review and meta-analysis","volume":"14","author":"Y Ren","year":"2017","journal-title":"Int Wound J"},{"key":"pone.0248799.ref016","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bjps.2018.05.052","article-title":"Treatment of keloid scars with intralesional triamcinolone and 5-fluorouracil injections\u2013a randomized controlled trial","volume":"72","author":"KE Hietanen","year":"2019","journal-title":"J Plast Reconstr Aesthetic Surg"},{"key":"pone.0248799.ref017","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.4103\/0366-6999.209896","article-title":"Radiation therapy in keloids treatment: History, strategy, effectiveness, and complication","volume":"130","author":"J Xu","year":"2017","journal-title":"Chin Med J (Engl)."},{"key":"pone.0248799.ref018","volume-title":"Radiation Therapy In The Treatment Of Keloids","author":"M Zainib","year":"2020"},{"key":"pone.0248799.ref019","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1111\/bjd.15667","article-title":"Adjuvant irradiation to prevent keloidal fibroproliferative growth should be standard of care","volume":"177","author":"MK Ramirez-Fort","year":"2017","journal-title":"Br J Dermatol"},{"key":"pone.0248799.ref020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0360-3016(93)90204-9","article-title":"The treatment of 783 keloid scars by iridium 192 interstitial irradiation after surgical excision","volume":"26","author":"P Escarmant","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"pone.0248799.ref021","first-page":"15","article-title":"Treatment of keloids with strontium 90 beta rays","volume":"24","author":"BC Deka","year":"1987","journal-title":"Indian J Cancer"},{"key":"pone.0248799.ref022","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/SAP.0b013e3180423b32","article-title":"Postoperative radiation protocol for keloids and hypertrophic scars: statistical analysis of 370 sites followed for over 18 months","volume":"59","author":"R Ogawa","year":"2007","journal-title":"Ann Plast Surg"},{"key":"pone.0248799.ref023","first-page":"7","article-title":"Diagnosis and Treatment of Keloids and Hypertrophic Scars\u2014Japan Scar Workshop Consensus Document 2018","author":"R Ogawa","year":"2019","journal-title":"Burn Trauma"},{"key":"pone.0248799.ref024","first-page":"313","article-title":"Ear keloids: a review and update of treatment options","volume":"86","author":"R Sobec","year":"2013","journal-title":"Clujul Med"},{"key":"pone.0248799.ref025","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1097\/01.PRS.0000056869.31142.DE","article-title":"Treatment of keloids by surgical excision and immediate postoperative single-fraction radiotherapy","volume":"111","author":"R Ragoowansi","year":"2003","journal-title":"Plast Reconstr Surg"},{"key":"pone.0248799.ref026","doi-asserted-by":"crossref","first-page":"205951311773548","DOI":"10.1177\/2059513117735483","article-title":"Brachytherapy in the adjuvant management of keloid scars: literature review","volume":"3","author":"I Goutos","year":"2017","journal-title":"Scars, Burn Heal"},{"key":"pone.0248799.ref027","article-title":"Surgical excision with adjuvant irradiation for treatment of keloid scars: A systematic review","volume":"3","author":"MCE Van Leeuwen","year":"2015","journal-title":"Plast Reconstr Surg-Glob Open"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0248799","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T13:51:43Z","timestamp":1616507503000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0248799"}},"subtitle":[],"editor":[{"given":"Steven Eric","family":"Wolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,3,23]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0248799","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,23]]}}}